Jerome, J.R.; Deliyanti, D.; Suphapimol, V.; Kolkhof, P.; Wilkinson-Berka, J.L.
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy. Int. J. Mol. Sci. 2023, 24, 2334.
https://doi.org/10.3390/ijms24032334
AMA Style
Jerome JR, Deliyanti D, Suphapimol V, Kolkhof P, Wilkinson-Berka JL.
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy. International Journal of Molecular Sciences. 2023; 24(3):2334.
https://doi.org/10.3390/ijms24032334
Chicago/Turabian Style
Jerome, Jack R., Devy Deliyanti, Varaporn Suphapimol, Peter Kolkhof, and Jennifer L. Wilkinson-Berka.
2023. "Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy" International Journal of Molecular Sciences 24, no. 3: 2334.
https://doi.org/10.3390/ijms24032334
APA Style
Jerome, J. R., Deliyanti, D., Suphapimol, V., Kolkhof, P., & Wilkinson-Berka, J. L.
(2023). Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy. International Journal of Molecular Sciences, 24(3), 2334.
https://doi.org/10.3390/ijms24032334